Source: Annual Congress 2004 - Epithelial cell functions in host defense and ion transport
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kändler, C. Beisswenger, T. Damm, B. Robert (Marburg, Germany). The endogenous antibiotic CRAMP is induced during pneumonia. Eur Respir J 2004; 24: Suppl. 48, 3432

Member's Comments

No comment yet.

Related content which might interest you: The antimicrobial peptide CRAMP protects against emphysema Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Influence of antibiotic pre-treatment on inflammatory markers in community-acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Frequency of side effects in antibiotic treatment for pneumonia Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 The antimicrobial molecule elafin protects the lung against Staphylococcus aureus infection Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Ventilator-associated pneumonia due to colistin susceptible-only microorganisms Source: Eur Respir J 2007; 30: 307-313 Year: 2007 PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by P. aeruginosa Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 In COPD moxifloxacin enhances th1-immune response in the presence of bacterial endotoxin by inducing IL-2 expression Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Effects of glucocorticoids in ventilated piglets with severe pneumonia Source: Eur Respir J 2008; 32: 1037-1046 Year: 2008 The antimicrobial peptide CRAMP is a regulator of inflammation during pneumonia Source: Annual Congress 2006 - Immunology of the airways Year: 2006 Pulmonary immunostimulation with macrophage-activating lipopeptide-2 in influenza-A-virus infected mice increased survival of subsequent pneumococcal pneumonia Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Antibiotic treatment for nosocomial pneumonia Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211 Year: 2004 Induction of cathelicidin (LL-37) in rhinovirus-induced COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Co-treatment with clarithromycin and dexamethasone on murine mycoplasma pneumoniae pneumonia model Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Incomplete angiopoietin-2 knockdown does not confer protection in murine pneumococcal pneumonia Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017 Inhaled antibiotics, pneumonia and bacterial resistance in the ICU Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018